Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this ...

That’s why one of the most closely watched elements of a company’s earnings report is the guidance it gives for the next ...

Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...

Sitting at a market capitalization of $159 billion, Amgen (AMGN) is a biotech powerhouse. Founded in 1980, it is one of the biggest names in the healthcare and biotech industry, with a strong history ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

INDIANAPOLIS—Lilly Endowment Inc., a major shareholder in Eli Lilly & Co. (NYSE:LLY), has recently sold a significant portion ...

We recently compiled a list of the 14 Best Large Cap Dividend Growth Stocks To Buy Now. In this article, we are going to take ...

Despite moving higher in early Friday trading, the stock market reversed its course and headed... Eli Lilly and Company (NYSE:LLY) today announced topline results from the LIBRETTO-431 study ...

This page features the latest news about the Eli Lilly DRC stock. Eli Lilly stock soars to all-time high of $967 amid robust growth Eli Lilly and Co's stock has reached an unprecedented peak ...